Skip to main content
. 2014 Aug 21;2(3):147–151. doi: 10.12954/PI.14056

Table 1.

Characteristics of patients

No. Age (yr) Therapy Histology Stage Adverse event
1 83 MAB Unknown cT4N1M1 Edema
2 77 MAB Gleason 4+3 cT2N0M1 None
3 80 MAB Gleason 4+3 cT3N1M1 None
4 77 MAB Gleason 3+4 cT2N0M1 None

MAB, maximum androgen blockade.